YEA CHRISTOPHER (Chief Development Officer) sold 1.9% of their position (4.35K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $67.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001691102-26-000002
Officer· Chief Development Officer
Since Sep 2018
-4.35K
Net shares
Net seller
$67.7K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
6.88K acquired · 11.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.7%
2/21/2026
224.17K→227.92K
Common Stock
Direct
Shares
+3.13K
Price / share
—
Trade value
—
% of position
1.4%
2/22/2026
227.92K→231.05K
Common Stock
Direct
Shares
−4.35K
Price / share
$15.57
Trade value
$67.67K
% of position
1.9%
2/23/2026
231.05K→226.70K
Total
Net shares
+2.53K
Net value
-$67.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | M · Option Exercise | +3.75K | — | — | 1.7% | 224.17K | 227.92K |
| Common Stock Direct | 2/22/2026 | M · Option Exercise | +3.13K | — | — | 1.4% | 227.92K | 231.05K |
| Common Stock Direct | 2/23/2026 | S · Sale | −4.35K | $15.57 | $67.67K | 1.9% | 231.05K | 226.70K |
| Total | +2.53K | -$67.67K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
45K
Exercisable
—
2/21/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
3.13K shares
Shares
−3.13K
Strike price
Held after
28.13K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.75K shares | 2/21/2026 | M · Option Exercise | −3.75K | — | 45K | |
| Restricted Stock Unit Direct | Common Stock3.13K shares | 2/22/2026 | M · Option Exercise | −3.13K | — | 28.13K |